CONFERENCE EXPORT REFORM BILL PROVIDES HHS WITH DETAILED CRITERIA FOR EXPANDING "TIER-ONE" LIST OF COUNTRIES; FDA CERTIFICATION FEE INCLUDED
This article was originally published in The Gray Sheet
Executive Summary
Export reform language reported out of conference March 27 would allow HHS to expand the bill's list of 24 industrialized countries to which unapproved devices and drugs could be exported without FDA clearance.